Previous Article | Next Article ![]()
J. Virol., Mar 1995, 1714-1719, Vol 69, No. 3
JP Li, HO Hu, QT Niu and C Fang
The leukemogenic membrane glycoprotein gp55, encoded by Friend spleen
focus-forming virus (SFFV), induces erythroid cell proliferation through
its interaction with the erythropoietin receptor (EPO-R). There are two
forms of gp55 in SFFV-infected cells: an intracellular form (more than 95%
of the total protein), which is localized within the endoplasmic reticulum
(ER) membranes, and a cell surface form (about 3 to 5%). Because both forms
of the viral proteins bind to EPO-R, it is not clear whether the viral
protein induces mitogenesis intracellularly or at the cell surface. To
address this question, we constructed an EPO- R mutant that contained a
6-amino-acid (DEKKMP) C-terminus ER retention signal. Biochemical and
functional analyses with this mutant indicated that it was completely
retained in the ER and not expressed at the cell surface. Further analysis
showed that the mutant, like the wild-type EPO-R, interacted with SFFV
gp55. However, this apparent intracellular interaction between the two
proteins failed to induce growth factor- independent proliferation of Ba/F3
cells. Furthermore, spontaneous variants of the ER-retained EPO-R selected
on the basis of their ability to induce cell proliferation when coexpressed
with gp55 were exclusively expressed at the cell surface. Thus, our results
support the hypothesis that the mitogenic activation of the EPO-R by gp55
requires the interaction of the two proteins at the cell surface.
Copyright © 1995, American Society for Microbiology
Cell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55
Department of Microbiology, New York University Medical Center, New York 10016.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|